Archives of endocrinology and metabolism · 2025
Association of copeptin levels in the postpartum period with gestational diabetes.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Soares Sofia Duarte, Dualib Patricia Medici, Giuffrida Fernando de Mello Almada, Almeida-Pititto Bianca de, Reis André Fernandes
Аннотация
OBJECTIVE: To investigate the association of copeptin levels in the postpartum period with previous gestational diabetes mellitus, as well as its cardiometabolic phenotypes and biomarkers.
METHODS: In this cross-sectional analysis, women followed at a specialized gestational diabetes mellitus outpatient clinic were studied. Eligibility criteria included age ≥ 18 years and body mass index > 25 kg/m2. Participants were divided into two groups: those with (n = 42) and without gestational diabetes mellitus (n = 43). In the postpartum period (2 to 6 months), between September 2018 and May 2020, blood samples were collected for measurement of copeptin and E-selectin (by enzyme-linked immunosorbent assay), adiponectin, blood glucose, insulin, glycated hemoglobin, lipid profile, thyroid stimulating hormone, and gamma-GT.
RESULTS: Eighty-five women were studied; 42 had previous gestational diabetes mellitus and 43 did not. There were no significant differences in copeptin levels between women with and without previous gestational diabetes mellitus (1.48 ± 0.66 versus 1.49 ± 0.68 pmol/L; p = 0.89). No associations were observed between copeptin levels and the other studied parameters. However, a positive association was found between copeptin and E-selectin levels in both groups (Kruskal-Wallis; p = 0.007).
CONCLUSION: Circulating copeptin levels were not associated with previous gestational diabetes mellitus or other related phenotypes in the postpartum period. A positive association was observed between copeptin and plasma E-selectin levels in women with and without previous gestational diabetes mellitus, which warrants further investigation.
METHODS: In this cross-sectional analysis, women followed at a specialized gestational diabetes mellitus outpatient clinic were studied. Eligibility criteria included age ≥ 18 years and body mass index > 25 kg/m2. Participants were divided into two groups: those with (n = 42) and without gestational diabetes mellitus (n = 43). In the postpartum period (2 to 6 months), between September 2018 and May 2020, blood samples were collected for measurement of copeptin and E-selectin (by enzyme-linked immunosorbent assay), adiponectin, blood glucose, insulin, glycated hemoglobin, lipid profile, thyroid stimulating hormone, and gamma-GT.
RESULTS: Eighty-five women were studied; 42 had previous gestational diabetes mellitus and 43 did not. There were no significant differences in copeptin levels between women with and without previous gestational diabetes mellitus (1.48 ± 0.66 versus 1.49 ± 0.68 pmol/L; p = 0.89). No associations were observed between copeptin levels and the other studied parameters. However, a positive association was found between copeptin and E-selectin levels in both groups (Kruskal-Wallis; p = 0.007).
CONCLUSION: Circulating copeptin levels were not associated with previous gestational diabetes mellitus or other related phenotypes in the postpartum period. A positive association was observed between copeptin and plasma E-selectin levels in women with and without previous gestational diabetes mellitus, which warrants further investigation.